135 related articles for article (PubMed ID: 33007093)
1. The diagnostic value of dual-phase SPECT/CT scintigraphy based on transport kinetics of 99mTc-sestamibi confirmed with histopathological findings in patients with secondary hyperparathyroidism - practical consideration.
Listewnik MH; Piwowarska-Bilska H; Safranow K; Ostrowski M; Iwanowski J; Chosia M; Birkenfeld B
Nucl Med Rev Cent East Eur; 2020; 23(2):71-77. PubMed ID: 33007093
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of ultrasonography, dual-phase
Zhang R; Zhang Z; Huang P; Li Z; Hu R; Zhang J; Qiu W; Hu P
BMC Med Imaging; 2020 Aug; 20(1):91. PubMed ID: 32746794
[TBL] [Abstract][Full Text] [Related]
3. Comparison of biochemical markers and technetium 99m methoxyisobutylisonitrile imaging in primary and secondary hyperparathyroidism.
Wang Y; Liu Y; Li N; Zhang W
Front Endocrinol (Lausanne); 2023; 14():1094689. PubMed ID: 37051197
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of 99m Tc-MIBI single-photon emission computed tomography/computed tomography fusion imaging for the diagnosis of secondary hyperparathyroidism.
Peng Y; Pan G; Zhao B; Zuo C; Wang Y; Chen R
Nucl Med Commun; 2023 Sep; 44(9):767-771. PubMed ID: 37395545
[TBL] [Abstract][Full Text] [Related]
5. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism.
Yang J; Hao R; Yuan L; Li C; Yan J; Zhen L
AJR Am J Roentgenol; 2014 Jan; 202(1):180-4. PubMed ID: 24370142
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.
Ning Y; Chen D; Huang Z; Lou C
Hell J Nucl Med; 2020; 23(2):148-157. PubMed ID: 32716406
[TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative method for the assessment of focal lesions in parathyroid scintigraphy with relation to histopathology: a prospective study.
Listewnik MH; Piwowarska-Bilska H; Kurantowicz M; Ostrowski M; Borowiecki A; Safranow K; Jasiakiewicz K; Iwanowski J; Chosia M; Laszczyńska M; Birkenfeld B
Nucl Med Rev Cent East Eur; 2017; 20(1):18-24. PubMed ID: 27813617
[TBL] [Abstract][Full Text] [Related]
8. Is dual-phase SPECT/CT with 99mTc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?
Lee SH; Shin E; Ha S; Oh JS; Song DE; Ryu JS
Medicine (Baltimore); 2020 May; 99(19):e19989. PubMed ID: 32384452
[TBL] [Abstract][Full Text] [Related]
9. The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism.
Zhen L; Li H; Liu X; Ge BH; Yan J; Yang J
Nucl Med Commun; 2013 May; 34(5):439-44. PubMed ID: 23458854
[TBL] [Abstract][Full Text] [Related]
10. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience.
Ciappuccini R; Morera J; Pascal P; Rame JP; Heutte N; Aide N; Babin E; Reznik Y; Bardet S
Clin Nucl Med; 2012 Mar; 37(3):223-8. PubMed ID: 22310246
[TBL] [Abstract][Full Text] [Related]
11. The role of
Jiang SQ; Yang T; Zou Q; Xu L; Ye T; Kang YQ; Li WR; Jiao J; Zhang Y
BMC Med Imaging; 2020 Oct; 20(1):115. PubMed ID: 33059621
[TBL] [Abstract][Full Text] [Related]
12. Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.
Xue J; Liu Y; Ji T; Zhao A; Liang Y; Deng H; Wang Q; Zhang Y; Yang L; Yang A
Nucl Med Commun; 2018 Dec; 39(12):1129-1137. PubMed ID: 30239472
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ⁹⁹mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ⁹⁹mTc-sestamibi scintigraphy, SPECT, US and CT.
Kim YI; Jung YH; Hwang KT; Lee HY
Ann Nucl Med; 2012 Dec; 26(10):804-10. PubMed ID: 22875576
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of anterior 180°
Cheng JL; Hsu CC; Wang PW; Sung KC; Chiu NT; Chiu LY; Huang YC
Ann Nucl Med; 2021 Feb; 35(2):203-210. PubMed ID: 33389667
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of planar, SPECT, and SPECT/CT parathyroid scintigraphy protocols in patients with hyperparathyroidism.
Raruenrom Y; Theerakulpisut D; Wongsurawat N; Somboonporn C
Nucl Med Rev Cent East Eur; 2018; 21(1):20-25. PubMed ID: 29319134
[TBL] [Abstract][Full Text] [Related]
17. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
18. Combined application of ultrasound and SPECT/CT has incremental value in detecting parathyroid tissue in SHPT patients.
Yuan LL; Kan Y; Ma DQ; Yang JG
Diagn Interv Imaging; 2016 Feb; 97(2):219-25. PubMed ID: 26432401
[TBL] [Abstract][Full Text] [Related]
19. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
Rubello D; Saladini G; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
